Orchestra BioMed Shares Drop More Than 11% After Offering Plan

John Kim

1 min read

Add as a preferred source on Google

Orchestra BioMed Shares Drop More Than 11% After Offering Plan

The biomedical innovation company plans an underwritten public offering of common stock.

By John Kim

Published Nov 7, 2026, 7:43 AM EST

A blank share certificate tilts beside a single glass vial / TokenPost.ai

Orchestra BioMed Holdings, Inc. announced plans for an underwritten public offering of common stock. Its shares fell more than 11% in extended trading Thursday, Nov. 5, following the announcement.

Orchestra BioMed is a biomedical innovation company.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.